Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
PHASE2
This Phase II clinical trial was designed for patients with hematologic mal...
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
PHASE2
RATIONALE: Giving low doses of chemotherapy, such as busulfan and fludarabi...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer
PHASE1
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride li...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill